Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Rubin

Chest

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Chest|October 1, 1985
Calcium channel blockers in primary pulmonary hypertensionL J Rubin
Chest|January 1, 1986
Long-term effects of nitrendipine on hemodynamics and oxygen transport in patients with cor pulmonaleL J Rubin, K Moser
Chest|March 14, 2000
Mortality from primary pulmonary hypertension in the United States, 1979-1996D E Lilienfeld, L J Rubin
Chest|March 1, 1986
Oxygen therapy titrated to raise mixed venous oxygen content in COPDM L Peil, L J Rubin
Chest|October 1, 1988
Effects of interleukin-2 on oxygen delivery and consumption in patients with advanced malignancyH J Silverman, J Abrams, L J Rubin
Chest|October 26, 1999
Continuous intravenous epoprostenol therapy for pulmonary hypertension in Gaucher's diseaseA E Bakst, S P Gaine, L J Rubin
Chest|November 18, 2000
Recreational use of aminorex and pulmonary hypertensionS P Gaine, L J Rubin, J J Kmetzo, et al.
Chest|August 24, 1999
Anastomotic pulmonary hypertension after lung transplantation for primary pulmonary hypertension: report of surgical correctionC M Soriano, S P Gaine, J V Conte, et al.
Chest|January 13, 2000
Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosusI M Robbins, S P Gaine, R Schilz, et al.
Chest|October 23, 1997
Distinctive clinical features of portopulmonary hypertensionP C Kuo, J S Plotkin, L B Johnson, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Chest|October 1, 1985
Calcium channel blockers in primary pulmonary hypertensionL J Rubin
Chest|January 1, 1986
Long-term effects of nitrendipine on hemodynamics and oxygen transport in patients with cor pulmonaleL J Rubin, K Moser
Chest|March 14, 2000
Mortality from primary pulmonary hypertension in the United States, 1979-1996D E Lilienfeld, L J Rubin
Chest|March 1, 1986
Oxygen therapy titrated to raise mixed venous oxygen content in COPDM L Peil, L J Rubin
Chest|October 1, 1988
Effects of interleukin-2 on oxygen delivery and consumption in patients with advanced malignancyH J Silverman, J Abrams, L J Rubin
Chest|October 26, 1999
Continuous intravenous epoprostenol therapy for pulmonary hypertension in Gaucher's diseaseA E Bakst, S P Gaine, L J Rubin
Chest|November 18, 2000
Recreational use of aminorex and pulmonary hypertensionS P Gaine, L J Rubin, J J Kmetzo, et al.
Chest|August 24, 1999
Anastomotic pulmonary hypertension after lung transplantation for primary pulmonary hypertension: report of surgical correctionC M Soriano, S P Gaine, J V Conte, et al.
Chest|January 13, 2000
Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosusI M Robbins, S P Gaine, R Schilz, et al.
Chest|October 23, 1997
Distinctive clinical features of portopulmonary hypertensionP C Kuo, J S Plotkin, L B Johnson, et al.
Pageof 2